Routine Postoperative Biomarkers for Early Detection of Anastomotic Leakage After Hartmann’s Reversal: A Comparative Study
This retrospective study of 86 patients undergoing Hartmann's reversal demonstrates that routine postoperative inflammatory biomarkers, particularly the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) measured on day 3, show clinically relevant discrimination for detecting anastomotic leakage, although no single marker proved statistically superior to the others.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a surgeon reconnects two ends of the intestine after a period of separation, the body's reaction to the healing process can be a double-edged sword. The surgery itself triggers a natural, widespread inflammation as tissues repair themselves, but if that inflammation persists or spikes unexpectedly, it can signal a serious problem: a leak at the connection site. This leak, where the internal seal fails, is one of the most dangerous complications following this specific type of bowel reconstruction. For decades, doctors have relied on a single blood test, measuring a protein called C-reactive protein, to help distinguish between normal healing and a dangerous leak. However, this protein is just one of several signals the body sends out, and it is not always clear if other, simpler blood counts might offer a clearer picture or if they should be used alongside the traditional test.
A team of researchers at the Hospital General de México set out to compare these different signals in patients undergoing Hartmann's reversal, a complex operation where the bowel is reconnected after a previous emergency surgery. They looked at 86 adults who had this procedure and tracked four specific measurements in their blood on the first, third, and fifth days after surgery. These measurements included the standard C-reactive protein, a ratio that combines this protein with albumin (a nutrient protein in the blood), and two counts derived from a standard blood test: the ratio of white blood cells that fight infection to those that regulate the immune response, and the ratio of platelets, which help blood clot, to those same immune-regulating cells. The goal was to see which of these numbers, if any, could most accurately predict which patients would develop a leak.
The researchers found that the timing of the test mattered more than the specific type of test. On the very first day after surgery, none of the measurements were very good at telling the difference between a patient who was healing normally and one who would develop a leak. This is likely because the body is still reacting to the trauma of the operation itself. However, by the third day, the picture became much clearer. The data showed that all four measurements improved in their ability to detect a leak, with one specific ratio standing out slightly above the rest. The ratio of platelets to immune-regulating cells reached its highest level of overall performance on the third day, with an accuracy score of 0.882, though it correctly identified patients with a leak 66.7% of the time. The other three measurements, including the traditional C-reactive protein, performed very similarly to this top marker, though none of them were statistically proven to be better than the others.
What makes these findings particularly useful for a doctor is not just the ability to spot a problem, but the ability to rule one out. The study highlighted that if a patient's third-day blood levels for these markers were low, it was extremely unlikely they had a leak. For instance, if the ratio of white blood cells was below a certain point, the chance of a leak was less than two percent. This suggests that these routine blood tests could serve as a reliable safety net, giving doctors confidence to discharge patients who are healing well while keeping a closer watch on those whose numbers are rising. The researchers noted that while the platelet ratio showed the highest overall performance numbers in their specific group, the differences between the four tests were small enough that no single one could be declared the definitive winner.
The study also revealed that the specific numbers used to flag a potential leak were unique to this group of patients and cannot be applied as universal rules for everyone. Because the study was relatively small, involving only 86 patients with just nine leaks, the researchers emphasized that these specific cutoff points need to be tested in larger groups of people before they can be used to make final medical decisions. They did not find evidence that one test was superior to the others, but they did confirm that waiting until the third day after surgery provides a much more accurate window for detection than testing immediately after the operation. Ultimately, the work suggests that a combination of these routine, inexpensive blood tests, read at the right time, offers a powerful way to monitor patients and catch complications early, potentially preventing severe outcomes without the need for more invasive or expensive diagnostic procedures.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.